Barclays PLC closed 3.32% short of its 52-week high of £2.99, which the company achieved on January 22nd.

NEW YORK — The National Basketball Association (NBA) announced today that the NBA Draft 2025 presented by State Farm will ...

In this episode of The Big Question, Barclays Europe CEO, Francesco Ceccato, joins Euronews’ business editor, Angela Barnes, ...

Shares of Barclays PLC BARC dropped 1.59% to £2.88 Monday, on what proved to be an all-around favorable trading session for ...

Barclays Plc is preparing for a wave of dealmaking on both sides of the Atlantic as newly installed President Donald Trump ...

UK banking giants are paying an average of just 1.42 percent on their easy access accounts - far below the market average of ...

Sarah Coles, head of Personal Finance at investment platform Hargreaves Lansdown, said: “If you were to pay in £300 a month ...

Barclays analyst Ramsey El Assal maintained a Buy rating on Visa (V – Research Report) today and set a price target of $361.00. The company’s ...

The average age of first-time buyer in the UK rose to almost 34 last year, according to Barclays’ proprietary data, as people ...

Ahead of the start of a busy 2025 cricket schedule, Barclays is today unveiled as the brand-new principal partner of MCC and ...

If Banco Santander’s Ana Botín wants to sell her British retail business, there’s an obvious buyer: Barclays boss C. S.

Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of $28.00.